Yunnan Botanee Bio-Technology Group Co Ltd (300957) — Cash Flow Quality Index
Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a Cash Flow Quality Index of 4.98x as of September 2025. Operating cash flow of CN¥125.55 Million exceeds net income of CN¥25.22 Million, indicating high earnings quality where cash backs reported profits. Also explore balance sheet size of Yunnan Botanee Bio-Technology Group Co L for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yunnan Botanee Bio-Technology Group Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Yunnan Botanee Bio-Technology Group Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Yunnan Botanee Bio-Technology Group Co L tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
Year-by-year earnings quality comparison for Yunnan Botanee Bio-Technology Group Co Ltd. For live market cap and the full company financial profile, see Yunnan Botanee Bio-Technology Group Co L (300957) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.93x | CN¥976.60 Million | CN¥505.72 Million | ▲ +37.5% |
| 2024 | 1.40x | CN¥694.87 Million | CN¥494.79 Million | ▲ +74.1% |
| 2023 | 0.81x | CN¥610.44 Million | CN¥756.80 Million | ▲ +10.1% |
| 2022 | 0.73x | CN¥769.45 Million | CN¥1.05 Billion | ▼ -45.1% |
| 2021 | 1.33x | CN¥1.15 Billion | CN¥864.06 Million | ▲ +68.3% |
| 2020 | 0.79x | CN¥431.03 Million | CN¥543.75 Million | ▼ -36.4% |
| 2019 | 1.25x | CN¥514.92 Million | CN¥413.06 Million | ▲ +217.8% |
| 2018 | 0.39x | CN¥102.20 Million | CN¥260.53 Million | ▼ -70.2% |
| 2017 | 1.32x | CN¥202.44 Million | CN¥153.63 Million | — |